Biomica Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Subsidiary
- Established
- 2016-02-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.biomicamed.com
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
Phase 1
Active, not recruiting
- Conditions
- Non-small Cell Lung CancerMelanomaRenal Cell Carcinoma
- Interventions
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Biomica Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT05354102
- Locations
- 🇮🇱
Rambam MC, Haifa, Israel
News
Evogene Completes First-in-Class AI Foundation Model for Small Molecule Design with 90% Precision
Evogene Ltd. has completed its generative AI foundation model version 1.0 for small molecule design, developed in collaboration with Google Cloud, achieving approximately 90% precision compared to 29% in traditional GPT AI models.